These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 28300769)

  • 1. Aptamers: Biomedical Interest and Applications.
    Romero-López C; Berzal-Herranz A
    Pharmaceuticals (Basel); 2017 Mar; 10(1):. PubMed ID: 28300769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
    Stoltenburg R; Reinemann C; Strehlitz B
    Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro RNA SELEX for the generation of chemically-optimized therapeutic RNA drugs.
    Urak KT; Shore S; Rockey WM; Chen SJ; McCaffrey AP; Giangrande PH
    Methods; 2016 Jul; 103():167-74. PubMed ID: 26972786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current approaches in SELEX: An update to aptamer selection technology.
    Darmostuk M; Rimpelova S; Gbelcova H; Ruml T
    Biotechnol Adv; 2015 Nov; 33(6 Pt 2):1141-61. PubMed ID: 25708387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids.
    Macedo B; Cordeiro Y
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
    Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
    Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SELEX methods on the road to protein targeting with nucleic acid aptamers.
    Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
    Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
    Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
    J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
    Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Progress and Opportunities for Nucleic Acid Aptamers.
    Byun J
    Life (Basel); 2021 Feb; 11(3):. PubMed ID: 33671039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA and RNA aptamers: from tools for basic research towards therapeutic applications.
    Ulrich H; Trujillo CA; Nery AA; Alves JM; Majumder P; Resende RR; Martins AH
    Comb Chem High Throughput Screen; 2006 Sep; 9(8):619-32. PubMed ID: 17017882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in aptamer screening and small molecule aptasensors.
    Kim YS; Gu MB
    Adv Biochem Eng Biotechnol; 2014; 140():29-67. PubMed ID: 23851587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures.
    Rahimizadeh K; AlShamaileh H; Fratini M; Chakravarthy M; Stephen M; Shigdar S; Veedu RN
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical applications of aptamers.
    Tombelli S; Minunni M; Mascini M
    Biosens Bioelectron; 2005 Jun; 20(12):2424-34. PubMed ID: 15854817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aptamers in the Treatment of Bacterial Infections: Problems and Prospects].
    Zeninskaya NA; Kolesnikov AV; Ryabko AK; Shemyakin IG; Dyatlov IA; Kozyr AV
    Vestn Ross Akad Med Nauk; 2016; 71(5):350-8. PubMed ID: 29297663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute quantification of cell-bound DNA aptamers during SELEX.
    Avci-Adali M; Wilhelm N; Perle N; Stoll H; Schlensak C; Wendel HP
    Nucleic Acid Ther; 2013 Apr; 23(2):125-30. PubMed ID: 23405949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies.
    Lipi F; Chen S; Chakravarthy M; Rakesh S; Veedu RN
    RNA Biol; 2016 Dec; 13(12):1232-1245. PubMed ID: 27715478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro selection of ssDNA aptamers using biotinylated target proteins.
    Mayer G; Höver T
    Methods Mol Biol; 2009; 535():19-32. PubMed ID: 19377986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aptamers: selection and scope of applications].
    Chauveau F; Pestourie C; Tavitian B
    Pathol Biol (Paris); 2006 May; 54(4):251-8. PubMed ID: 16678359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA aptamers: from basic science towards therapy.
    Ulrich H
    Handb Exp Pharmacol; 2006; (173):305-26. PubMed ID: 16594622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.